CPE White Paper on antimicrobial resistance threatening cancer care: 50% deaths linked to infections, policy recommendations for EU institutions and Member States. Read More
CPE factsheet explains subcutaneous administration of cancer treatments: benefits, how it works, patient eligibility, and advantages over IV infusion. Read More
PCE and CPE’s February 2023 webinar report examines opportunities and challenges of the EU HTA Regulation with EC, MEPs, ESMO, EFPIA, and patient advocates. Read More
European health organisations including CPE issue recommendations on EHDS opt-out mechanism to protect research while ensuring data representativeness and equity. Read More
This Manifesto, led by the European Association of Urology and co-signed by Cancer Patients Europe and other stakeholders, addresses the continence health challenge affecting… Read More
CPE’s position paper responds to the European Commission’s consultation on EMA-HTA cooperation, calling for inclusive patient engagement and streamlined processes. Read More
Patient organisations release 10 recommendations for meaningful patient involvement in Joint Clinical Assessments under the EU HTA Regulation. Read More
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
CPE supports the ASCERTAIN project survey on Cost-Effectiveness Thresholds in healthcare. Share your views to help shape equitable HTA tools across Europe. Read More
CPE and CECOG call on EU institutions to pilot cancer indicators in the European Semester and develop a Cancer Inequalities Dashboard to reduce disparities in care. Read More